There is a moment in every large system when a perfectly reasonable task becomes absurd. A benefit exists. A person may qualify. A staff member wants to help. Yet between those three facts sit a dozen tabs, a stack of forms, scattered rules and a clock with poor manners. Israel “Srulik” Dvorsky built TailorMed around that moment.
His company operates in the administrative distance between money that has been set aside for assistance and the people it is meant to reach. TailorMed’s software helps provider and pharmacy teams identify possible support, manage eligibility and enrollment, follow claims and track drug orders. The company also offers patient-facing tools and services for organizations whose own teams lack the capacity to do every piece of the work.
It is not the sort of problem that yields to a grand unveiling. Every hospital has its habits. Every integration has dependencies. Every assistance program arrives with rules, dates and exceptions. Dvorsky’s answer has been an operator’s answer: start with the sharpest workflow, get close enough to see how people really handle it, measure the result, and only then ask for more territory.
An engineer meets the maze
Dvorsky grew up in Israel and nearly made a career of playing saxophone. Engineering won. He earned a bachelor’s degree in electrical engineering from Tel Aviv University, followed by a global MBA at the institution now called Reichman University. Before TailorMed, he spent roughly a decade in medical devices at BrainsGate, eventually leading research and development and operations.
That background matters because engineers are trained to distrust a vague handoff. Electricity should go somewhere. A signal should mean something. A component should behave consistently under stress. Administrative work is more unruly, but it is still a system, and its failures often occur at the joins: data in one place, a rule in another, a task owned by nobody in particular.
“We did a lot of homework to understand the dynamics and main players of the US healthcare industry.”Israel Dvorsky
Dvorsky and co-founder Adam Siton did not enter American healthcare pretending to know its every corridor. They studied the value chain and looked for a technology wedge that made sense to each party touching the process. Dvorsky brought hardware, medical-device and operating experience. Siton, TailorMed’s chief technology officer, brought a software background. In 2016 they put those complementary instincts behind a company.
The pilot is the pitch
The useful thing about Dvorsky’s strategy is its order. TailorMed began with providers, where counselors and pharmacy technicians were already doing the patient-by-patient work. The product could sit inside an existing routine, connect to records and revenue systems, and make the search and enrollment process more systematic. A pilot reduced risk for the customer and gave the company a scorecard.
This is a quieter form of sales. The pitch is not merely that the software can work. The pilot demonstrates where it works, who uses it, and what changes when they do. Dvorsky has described a tight feedback loop built from on-site observation, advisory boards and usage data. Each source catches a different truth. A meeting reveals intention. A site visit reveals improvisation. Product telemetry reveals what survived contact with Tuesday afternoon.
His interest in the craft of product building was visible before TailorMed had a national footprint. In public essays from 2014 and 2015, Dvorsky wrote about talent, teammates, and the difference between good and bad product management. The titles are plain, almost notebook-like. They suggest an executive who treats management as a discipline to be examined, rather than a personality trait one either receives at birth or does not.
That mindset is particularly useful when the customer is not a single person. A hospital buyer may care about revenue and staffing. The employee using the product may care about clicks, queues and whether information is where it ought to be. A pharmacy may see an unfilled prescription. A manufacturer may see low participation in a support program. TailorMed has to make one workflow legible to several parties without confusing their different incentives.
Once the provider workflow had traction, TailorMed extended the model to pharmacies, where an unaffordable prescription can simply be abandoned. Then it moved toward life-sciences companies and their support programs. The expansion was less a leap than a chain: one participant already had useful connections to the next.
A network made of kept promises
“Network” is one of those business words that can arrive overdressed. In practice, TailorMed’s network is made of unromantic things: permissions, integrations, staff habits, enrollment records and timely follow-up. Its advantage depends on connecting organizations without asking every participant to abandon the tools and relationships they already use.
The company’s 2021 acquisition of Vivor added another provider and pharmacy platform to that project. Acquisitions look tidy in a timeline and untidy everywhere else. Products overlap. Customers need reassurance. Teams compare vocabulary. The strategic point, however, was legible: more reach and more workflow density could make the combined network more useful.
There is also a geographic education inside this company story. TailorMed was founded by Israeli technologists for a problem whose rules are emphatically American. Dvorsky has spoken about the homework required to understand the U.S. system and its many actors. Moving from Israel to New York put him nearer the market, but proximity is not the same as fluency. Fluency came through implementations, customer conversations and the slow discovery of which seemingly small details can stall an entire process.
By 2024, TailorMed had become easier to notice. Deloitte ranked the company number 58 on its Technology Fast 500, citing 2,408 percent growth over three years. In November, TailorMed announced $40 million in equity and debt financing, with Windham Capital Partners leading the equity portion and Poalim Tech leading the debt. The round brought a longer roster of health systems, strategic investors and financial institutions around the table.
Those figures are milestones, not explanations. The explanation sits further down the stack: a narrow task became a repeatable workflow; the workflow became an integration; the integration became a relationship; enough relationships began to resemble infrastructure. Compounding is impressive at the end and mostly repetitive in the middle.
The financing also widened the company’s obligations. Capital asks for speed; healthcare customers ask for care, continuity and proof. Dvorsky’s job is to make those tempos coexist. A growth plan can add new products and partners, but an implementation still succeeds one organization at a time. This is where the founder becomes an operator in the fullest sense: translating an expansive promise into priorities that engineers, service teams and customers can recognize on Monday morning.
The discipline of two horizons
A company can become trapped by the problem that gave it a start. It can also wander away from the useful thing customers already pay it to do. Dvorsky’s current task is to avoid both errors.
He has framed TailorMed’s next chapter in two parts. One is continued depth: more providers, more pharmacies and broader life-sciences collaboration. The other is a move beyond identifying assistance toward more predictive support and wider medication workflows. That includes spotting financial risk earlier, improving the path from prescription to access, and exploring adherence and payer relationships.
“While the patient is at the center, the problem is system-wide.”Israel Dvorsky
Artificial intelligence appears in this plan as capacity, not confetti. Dvorsky has discussed using it across engineering, service automation and product copilots. The test is practical: can a team handle more work, can a repetitive step happen faster, can the next best action become clearer? In a regulated, trust-sensitive environment, novelty is a poor substitute for reliability.
This creates an interesting management rhythm. Protect the core product while seeding the next one. Stay close to today’s users while imagining tomorrow’s network. Keep the organization lean and communication direct even as partnerships multiply. The contradiction cannot be solved once; it must be managed every week.
Listening as operating leverage
The saxophone detail lingers. Music is not a blueprint for company-building, and a founder profile should resist turning every hobby into destiny. Still, the instrument rewards timing, breath and attention to everyone else in the room. Dvorsky’s public comments about building TailorMed return repeatedly to the same habits: stay near the customer, begin small, and let evidence earn the next movement.
His career has moved from hardware to software, from one device company to a many-sided network, and from Israel to New York. The common thread is less romantic than invention. It is integration. Make separate parts behave like a system. Find the awkward handoff. Give someone a clearer next step.
That may be the most portable lesson in TailorMed’s story. Complicated industries rarely need another person announcing that they are complicated. They need builders willing to learn the local grammar, sit beside the work and remove one obstruction without creating two more. The ambition can be large. The unit of progress is usually small.
Dvorsky’s wager is that enough small improvements can change the shape of the whole journey. A form found sooner. A program matched correctly. A task no longer stranded between systems. Administrative victories do not make much noise, which may be why they are easy to underestimate. Then again, a network is just a series of quiet connections that keep working when someone needs them.